How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa.
HIV
HPV
cervical cancer
microbiome
sub-saharan Africa
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2020
2020
Historique:
received:
05
09
2019
accepted:
15
01
2020
entrez:
3
3
2020
pubmed:
3
3
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Despite ongoing efforts, sub-Saharan Africa faces a higher cervical cancer burden than anywhere else in the world. Besides HPV infection, definitive factors of cervical cancer are still unclear. Particular states of the cervicovaginal microbiota and viral infections are associated with increased cervical cancer risk. Notably, HIV infection, which is prevalent in sub-Saharan Africa, greatly increases risk of cervicovaginal dysbiosis and cervical cancer. To better understand and address cervical cancer in sub-Saharan Africa, a better knowledge of the regional cervicovaginal microbiome is required This review establishes current knowledge of HPV, HIV, cervicovaginal infections, and the cervicovaginal microbiota in sub-Saharan Africa. Because population statistics are not available for the region, estimates are derived from smaller cohort studies. Microbiota associated with cervical inflammation have been found to be especially prevalent in sub-Saharan Africa, and to associate with increased cervical cancer risk. In addition to high prevalence and diversity of HIV and HPV, intracellular bacterial infections such as Chlamydia, Gonorrhea, and
Identifiants
pubmed: 32117800
doi: 10.3389/fcimb.2020.00023
pmc: PMC7028704
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
23Subventions
Organisme : NCI NIH HHS
ID : U54 CA190155
Pays : United States
Informations de copyright
Copyright © 2020 Klein, Kahesa, Mwaiselage, West, Wood and Angeletti.
Références
J Infect Dis. 2008 Oct 15;198(8):1131-40
pubmed: 18717638
PLoS One. 2015 Aug 12;10(8):e0135602
pubmed: 26267867
Sex Transm Dis. 2007 Nov;34(11):864-9
pubmed: 17621244
J Infect Dis. 2014 Dec 1;210(11):1723-33
pubmed: 24943724
Acta Obstet Gynecol Scand. 2002 Sep;81(9):886-93
pubmed: 12225308
Epidemiol Infect. 2016 Jan;144(1):123-37
pubmed: 26062721
mBio. 2019 Feb 19;10(1):
pubmed: 30782659
BMC Public Health. 2014 Dec 23;14:1320
pubmed: 25539861
BMC Infect Dis. 2014 Jan 31;14:51
pubmed: 24484380
Int J Gynecol Cancer. 2015 Jun;25(5):919-25
pubmed: 25950128
Transl Res. 2017 Jan;179:168-182
pubmed: 27477083
Sex Transm Infect. 2011 Dec;87 Suppl 2:ii10-13
pubmed: 22110143
Curr Opin Oncol. 2003 Sep;15(5):382-8
pubmed: 12960521
BMC Infect Dis. 2011 Jan 11;11:10
pubmed: 21223574
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Int J STD AIDS. 2000 Mar;11(3):176-9
pubmed: 10726942
Lancet. 1999 Mar 13;353(9156):869-73
pubmed: 10093978
J Med Virol. 2015 Sep;87(9):1594-600
pubmed: 26037775
Eur J Obstet Gynecol Reprod Biol. 1998 Oct;81(1):51-4
pubmed: 9846714
Front Oncol. 2014 Mar 14;4:48
pubmed: 24672770
Virol J. 2014 Jan 15;11:5
pubmed: 24433568
Cancer Med. 2015 Oct;4(10):1589-98
pubmed: 26194784
AIDS. 2015 Jan 2;29(1):59-66
pubmed: 25387313
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):765-73
pubmed: 24302677
Front Microbiol. 2018 Oct 23;9:2533
pubmed: 30405584
BMC Infect Dis. 2013 Nov 05;13:521
pubmed: 24192311
BMJ Clin Evid. 2008 Mar 10;2008:
pubmed: 19450319
Int J STD AIDS. 2012 Aug;23(8):581-4
pubmed: 22930296
J Clin Virol. 2013 Dec;58(4):696-702
pubmed: 24210330
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:7-9
pubmed: 26026728
Virol J. 2015 Jan 16;12:2
pubmed: 25591541
Obstet Gynecol. 2009 Jan;113(1):26-31
pubmed: 19104356
Infect Dis Obstet Gynecol. 2014;2014:498048
pubmed: 25389377
Ethiop Med J. 2014 Jan;Suppl 1:49-52
pubmed: 24696989
Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1087-90
pubmed: 25630539
Int J Cancer. 2012 Nov 15;131(10):2349-59
pubmed: 22323075
Sex Transm Infect. 2011 Aug;87(5):372-6
pubmed: 21471141
Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):153-7
pubmed: 18760524
Afr J Reprod Health. 2015 Mar;19(1):133-9
pubmed: 26103703
Biochem Biophys Res Commun. 2016 Jan 22;469(4):967-77
pubmed: 26718401
Ghana Med J. 2016 Sep;50(3):142-148
pubmed: 27752188
Mil Med Res. 2016 Feb 13;3:4
pubmed: 26877884
West Afr J Med. 2007 Jan-Mar;26(1):28-31
pubmed: 17595988
Cancer Causes Control. 1997 Sep;8(5):755-63
pubmed: 9328198
J Med Virol. 2013 Feb;85(2):282-7
pubmed: 23160919
PLoS One. 2012;7(3):e32728
pubmed: 22412914
Curr Issues Mol Biol. 2011;13(2):25-36
pubmed: 21220789
BJOG. 2020 Jan;127(2):171-180
pubmed: 31237400
Clin Lab Med. 2014 Dec;34(4):733-45
pubmed: 25439273
J Infect Dis. 2016 Jun 1;213(11):1828-35
pubmed: 26783349
Int J Gynaecol Obstet. 2013 Dec;123(3):231-5
pubmed: 24095308
J Cell Mol Med. 2012 Dec;16(12):3096-104
pubmed: 22978795
J Med Virol. 2015 Oct;87(10):1769-76
pubmed: 25963674
J Infect Dis. 2016 Nov 1;214(9):1361-1369
pubmed: 27521363
J Antimicrob Chemother. 2013 Sep;68(9):2015-25
pubmed: 23657804
J Infect Dis. 2013 Jun 1;207(11):1713-22
pubmed: 23345339
Sao Paulo Med J. 2013;131(6):405-10
pubmed: 24346780
J Clin Med. 2015 Apr 02;4(4):579-92
pubmed: 26239348
Ann Clin Microbiol Antimicrob. 2011 Feb 17;10:8
pubmed: 21329492
Sci Rep. 2015 Nov 17;5:16865
pubmed: 26574055
J Infect Public Health. 2015 Jan-Feb;8(1):1-10
pubmed: 25294086
Clin Ther. 2014 Jan 1;36(1):38-45
pubmed: 24417784
ISRN Obstet Gynecol. 2012;2012:240190
pubmed: 22900198
BMC Infect Dis. 2013 Aug 13;13:373
pubmed: 23941096
Eur J Gynaecol Oncol. 2003;24(5):401-4
pubmed: 14584656
ISME J. 2014 Sep;8(9):1781-93
pubmed: 24599071
BMC Infect Dis. 2015 Mar 04;15:115
pubmed: 25879811
J Infect Dev Ctries. 2011 Mar 21;5(3):176-81
pubmed: 21444986
PLoS One. 2016 Apr 26;11(4):e0153274
pubmed: 27115350
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Open Virol J. 2013;7:19-27
pubmed: 23494633
Transl Res. 2012 Oct;160(4):267-82
pubmed: 22683415
Acta Cytol. 2015;59(5):391-8
pubmed: 26674365
PLoS One. 2015 Apr 14;10(4):e0122488
pubmed: 25875167
Int J Cancer. 2018 Aug 1;143(3):621-634
pubmed: 29479697
Sex Transm Infect. 2015 Sep;91(6):440-4
pubmed: 25746041
Papillomavirus Res. 2019 Jun;7:154-163
pubmed: 30986570
J Immunoassay Immunochem. 2015;36(6):622-38
pubmed: 25774633
Int J STD AIDS. 2018 May;29(6):531-539
pubmed: 29198180
AIDS. 2010 Apr 24;24(7):1035-42
pubmed: 20397287
Hum Reprod Update. 2019 May 1;25(3):298-325
pubmed: 30938752
FEMS Microbiol Rev. 2013 Sep;37(5):762-92
pubmed: 23789590
Trop Med Int Health. 2012 Dec;17(12):1432-40
pubmed: 23107344
Cytopathology. 2013 Aug;24(4):264-71
pubmed: 22817687
J Natl Cancer Inst. 2004 Jul 21;96(14):1070-6
pubmed: 15265968
BMC Infect Dis. 2012 Feb 08;12:33
pubmed: 22316377
EBioMedicine. 2019 Jun;44:675-690
pubmed: 31027917
BMC Infect Dis. 2013 Sep 30;13:453
pubmed: 24079603
Microbiome. 2016 Nov 1;4(1):58
pubmed: 27802830
Vaccine. 2013 Dec 29;31 Suppl 5:F32-46
pubmed: 24331746
Sex Transm Dis. 2013 Jul;40(7):592-8
pubmed: 23965778
Int J Gynaecol Obstet. 1992 Mar;37(3):185-91
pubmed: 1351005
Infect Agent Cancer. 2016 Apr 06;11:17
pubmed: 27053945
Cancer Epidemiol. 2014 Aug;38(4):369-75
pubmed: 24852136
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
Int J Gynecol Cancer. 2013 May;23(4):716-23
pubmed: 23455757